Sign up for a free trial now
  • Login
  • Subscribe
  • Take a FREE Trial
  • About Us
  • Contact us
  • RSS

19 June 2013


The Pharma Letter
  • Home
  • 7 Day Premium Trial
  • Pharmaceuticals
  • Biotechnology
  • Generics
  • Events
  • Companies
  • Drugs
  • Subscribe

Pentosan Polysulfate Sodium Capsules Articles

UK MRC concludes that PPS not effective in vCJD

17 July 2006

J&J ends Alza JV for E-TRANS - update

23 February 2000

UK DoH discounts pentosan use for CJD

24 February 1999

Latest US results for full year 1998 again show strong sales growth

4 February 1999

Healthy Second-Quarter Growth For US Drug Firms

29 July 1998

Latest Wave Of US 1st Quarter Results

7 May 1998

Trend For 1997 Strong Sales Continues In USA

5 February 1998

US Generic, Drug Delivery Firms Discuss Strategies

3 June 1996

IVAX' Cystitis Drug Set For US Clearance

11 March 1996

IVAX SEES NICHEPRODUCTS AS ITS FUTURE

20 December 1993

FOCUS ON IVAX PRODUCT PIPELINE

12 October 1992

Showing 1-11 of 11 articles

Go to beginningPrevious
  • 1
NextGo to end
  • Hot Topics
  • Most Read
  • InSite Vision joins Merck & Co and Pfizer in patent infringement law suit against
  • Osteoporosis drug bazedoxifene stops growth of breast cancer cells, even in resistant tumors
  • Highlights of EHA meeting: Novartis' Jakavi; Bristol-Myers and AbbVie's elotuzumab; Janssen's ibrutinib
  • Additional indications in Japan for Roche's Avastin and Astellas' Prograf
  • US Supreme Court says patent settlement can "sometimes" be illegal
  • InSite Vision joins Merck & Co and Pfizer in patent infringement law suit against
  • Osteoporosis drug bazedoxifene stops growth of breast cancer cells, even in resistant tumors
  • Highlights of EHA meeting: Novartis' Jakavi; Bristol-Myers and AbbVie's elotuzumab; Janssen's ibrutinib
  • Additional indications in Japan for Roche's Avastin and Astellas' Prograf
  • US Supreme Court says patent settlement can "sometimes" be illegal

30 Day Premium Trial


Events

Twitter Right banner

RSS



© 2013 thepharmaletter.com

  • Home
  • RSS
  • About Us
  • Subscribe
  • Terms and Conditions
  • Article Archive
Site powered by WORKSsitebuilder CMS